Agile Therapeutics Company Profile (NASDAQ:AGRX)

About Agile Therapeutics

Agile Therapeutics logoAgile Therapeutics, Inc. is a women's health specialty pharmaceutical company. The Company is focused in the development and commercialization of prescription contraceptive products. The Company has developed a transdermal patch technology, called Skinfusion. The Company's lead product candidate is Twirla, also known as AG200-15, is a combined hormonal contraceptive (CHC) patch. In addition to Twirla, the Company is developing a pipeline of other new transdermal contraceptive products, including AG200-ER, which is a regimen designed to allow a woman to extend the length of her cycle; AG200-SP, which is a regimen designed to provide a shortened hormone-free interval, and AG890, which is a progestin-only contraceptive patch intended for use by women who are unable or unwilling to take estrogen. Each of its product candidates utilizes its Skinfusion technology designed to deliver contraceptive-levels of hormones to the blood stream through the skin over a seven-day period.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: AGRX
  • CUSIP:
Key Metrics:
  • Previous Close: $7.25
  • 50 Day Moving Average: $7.19
  • 200 Day Moving Average: $6.85
  • 52-Week Range: $28,752,000.00 - $5.32
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.85
  • P/E Growth: 0.00
  • Market Cap: $208.45M
  • Outstanding Shares: 28,752,000
  • Beta: 2.66
Profitability:
  • Return on Equity: -65.65%
  • Return on Assets: -44.64%
Debt:
  • Debt-to-Equity Ratio: 0.19%
  • Current Ratio: 6.06%
  • Quick Ratio: 6.06%
Additional Links:
Companies Related to Agile Therapeutics:

Analyst Ratings

Consensus Ratings for Agile Therapeutics (NASDAQ:AGRX) (?)
Ratings Breakdown: 5 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $16.60 (128.97% upside)

Analysts' Ratings History for Agile Therapeutics (NASDAQ:AGRX)
Show:
DateFirmActionRatingPrice TargetDetails
8/9/2016Noble FinancialReiterated RatingBuy$15.00View Rating Details
6/17/2016FBR & CoReiterated RatingBuyView Rating Details
5/31/2016Cantor FitzgeraldReiterated RatingBuyView Rating Details
2/2/2016Royal Bank Of CanadaReiterated RatingOutperform$13.00 -> $15.00View Rating Details
11/10/2015William BlairReiterated RatingBuy$18.00View Rating Details
12/30/2014Sterne Agee CRTInitiated CoverageBuyView Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Agile Therapeutics (NASDAQ:AGRX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
8/8/2016Q2($0.29)($0.29)ViewN/AView Earnings Details
5/9/2016Q1($0.38)($0.27)ViewN/AView Earnings Details
8/13/2015($0.37)($0.38)ViewN/AView Earnings Details
5/12/2015($0.35)($0.35)ViewN/AView Earnings Details
3/26/2015($0.40)($0.37)ViewN/AView Earnings Details
11/13/2014($0.50)($0.34)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Agile Therapeutics (NASDAQ:AGRX)
Current Year EPS Consensus Estimate: $-1.26 EPS
Next Year EPS Consensus Estimate: $-1.24 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.46)($0.30)($0.38)
Q2 20162($0.29)($0.27)($0.28)
Q3 20162($0.34)($0.32)($0.33)
Q4 20162($0.33)($0.24)($0.29)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Agile Therapeutics (NASDAQ:AGRX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Agile Therapeutics (NASDAQ:AGRX)
Insider Ownership Percentage: 3.50%
Institutional Ownership Percentage: 84.13%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/27/2016Jay MoorinMajor ShareholderBuy393,700$6.35$2,499,995.00View SEC Filing  
6/2/2015Alfred AltomariCEOBuy2,500$8.73$21,825.00View SEC Filing  
1/23/2015Jay MoorinMajor ShareholderBuy811,966$5.85$4,750,001.10View SEC Filing  
5/29/2014Care Capital Iii LlcMajor ShareholderBuy500,000$6.00$3,000,000.00View SEC Filing  
5/23/2014Andrew N SchiffDirectorBuy1,333,333$6.00$7,999,998.00View SEC Filing  
5/22/2014Ab InvestorMajor ShareholderBuy1,000,000$6.00$6,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Agile Therapeutics (NASDAQ:AGRX)
DateHeadline
fool.com logo3 Clinical-Stage Biotech Stocks With News About To Break (NASDAQ:AGRX)
www.fool.com - September 18 at 8:10 AM
biz.yahoo.com logoAGILE THERAPEUTICS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financial (NASDAQ:AGRX)
biz.yahoo.com - August 27 at 8:09 AM
News IconAgile Therapeutics Reports Second Quarter 2016 Financial Results (NASDAQ:AGRX)
www.pharmiweb.com - August 9 at 9:46 PM
4-traders.com logoAgile Therapeutics : reports 2Q loss (NASDAQ:AGRX)
www.4-traders.com - August 9 at 9:46 PM
twst.com logoAgile Therapeutics Inc.: Agile Therapeutics Reports Second Quarter 2016 Financial Results (NASDAQ:AGRX)
www.twst.com - August 9 at 9:46 PM
sg.finance.yahoo.com logoAgile Therapeutics reports 2Q loss (NASDAQ:AGRX)
sg.finance.yahoo.com - August 8 at 8:50 PM
biz.yahoo.com logoQ2 2016 Agile Therapeutics Inc Earnings Release - After Market Close (NASDAQ:AGRX)
biz.yahoo.com - August 8 at 8:10 AM
publicnow.com logoAgile Therapeutics Appoints Seth H. Z. Fischer to its Board of Directors (NASDAQ:AGRX)
www.publicnow.com - July 28 at 4:18 PM
finance.yahoo.com logoWhy Agile Therapeutics (AGRX) Stock Might be a Great Pick (NASDAQ:AGRX)
finance.yahoo.com - July 21 at 8:42 AM
rttnews.com logoSAGE On A High, JUNO Rockets As FDA Lifts Clinical Hold, FDA Panel Nod For AMGN (NASDAQ:AGRX)
www.rttnews.com - July 13 at 11:26 AM
biz.yahoo.com logoAGILE THERAPEUTICS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:AGRX)
biz.yahoo.com - July 13 at 8:32 AM
publicnow.com logoAgile Therapeutics Announces Plans to Advance Contraceptive Pipeline (NASDAQ:AGRX)
www.publicnow.com - July 12 at 4:23 PM
biz.yahoo.com logoAGILE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial Stateme (NASDAQ:AGRX)
biz.yahoo.com - July 6 at 4:32 PM
publicnow.com logoAgile Therapeutics Strengthens Executive Leadership Team with New Chief Commercial Officer (NASDAQ:AGRX)
www.publicnow.com - July 6 at 4:31 PM
4-traders.com logoAgile Therapeutics : to Present at the Cantor Fitzgeralds 2nd Annual Healthcare Conference (NASDAQ:AGRX)
www.4-traders.com - June 24 at 3:21 PM
publicnow.com logoAgile Therapeutics to Present at the Cantor Fitzgerald's 2nd Annual Healthcare Conference (NASDAQ:AGRX)
www.publicnow.com - June 23 at 4:19 PM
finance.yahoo.com logoAgile Therapeutics to Present at the Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:AGRX)
finance.yahoo.com - June 23 at 4:10 PM
finance.yahoo.com logo8:00 am Agile Therapeutics issued patent that includes claims covering the formulation of a progestin-only transdermal patch containing levonorgestrel and is expected to expire in 2032 (NASDAQ:AGRX)
finance.yahoo.com - June 16 at 8:00 AM
finance.yahoo.com logoAgile Therapeutics Announces Issuance of Patent for Progestin Patch Designs (NASDAQ:AGRX)
finance.yahoo.com - June 16 at 8:00 AM
biz.yahoo.com logoAGILE THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:AGRX)
biz.yahoo.com - June 8 at 4:17 PM
publicnow.com logoAgile Therapeutics to Present at the William Blair & Company's 36th Annual Growth Stock Conference (NASDAQ:AGRX)
www.publicnow.com - June 7 at 8:18 AM
finance.yahoo.com logoAgile Therapeutics to Present at the William Blair & Company’s 36th Annual Growth Stock Conference (NASDAQ:AGRX)
finance.yahoo.com - June 7 at 8:00 AM
capitalcube.com logoAgile Therapeutics, Inc. :AGRX-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016 (NASDAQ:AGRX)
www.capitalcube.com - June 6 at 2:26 PM
fool.com logoThese Billionaires Just Made a Killing on Celator. Here's What Else They've Been Buying (NASDAQ:AGRX)
www.fool.com - May 31 at 5:44 PM
finance.yahoo.com logoCan Agile Therapeutics (AGRX) Run Higher on Strong Earnings Estimate Revisions? (NASDAQ:AGRX)
finance.yahoo.com - May 31 at 8:52 AM
News IconAgile Therapeutics (AGRX) – Investment Analysts' Weekly Ratings Updates - Let Me Know About This (NASDAQ:AGRX)
www.lmkat.com - May 30 at 6:21 PM
News IconStock Rating Review for Agile Therapeutics, Inc. (NASDAQ:AGRX) - HNN (NASDAQ:AGRX)
hintsnewsnetwork.com - May 29 at 11:15 PM
cchdailynews.com logoCaxton Corp Increased Agile Therapeutics INC (NASDAQ:AGRX) by $8.44 Million as Shares Declined - CCH Daily News (NASDAQ:AGRX)
cchdailynews.com - May 28 at 6:13 PM
kcregister.com logoFast Moving Stocks: Agile Therapeutics, (NASDAQ:AGRX), Oracle (NYSE:ORCL), bluebird bio, (NASDAQ:BLUE ... - KC Register (NASDAQ:AGRX)
www.kcregister.com - May 25 at 9:32 AM
News IconEarnings Review and Stock Rundown for Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX)
hintsnewsnetwork.com - May 25 at 9:32 AM
News IconTarget Check and Stock Performance Recap Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX)
hintsnewsnetwork.com - May 24 at 6:23 PM
News IconStock Rating Review for Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX)
hintsnewsnetwork.com - May 22 at 10:51 PM
News IconLatest Analyst Ratings For Agile Therapeutics, Inc. (AGRX) - Share Trading News (NASDAQ:AGRX)
www.sharetrading.news - May 20 at 9:50 AM
News IconShare Recap and Earnings Focus on Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX)
hintsnewsnetwork.com - May 18 at 6:17 PM
News IconShare Performance and Target Price Review for Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX)
hintsnewsnetwork.com - May 17 at 11:15 PM
finance.yahoo.com logoAGILE THERAPEUTICS INC Financials (NASDAQ:AGRX)
finance.yahoo.com - May 17 at 1:04 PM
News IconConsensus Rating Review for Agile Therapeutics, Inc. (NASDAQ:AGRX) - Wall Street Hints and News (NASDAQ:AGRX)
hintsnewsnetwork.com - May 16 at 6:02 PM
kcregister.com logoMorning Watch List:Agile Therapeutics, Inc. (NASDAQ:AGRX), Winthrop Realty Trust (NYSE:FUR), Facebook Inc ... - KC Register (NASDAQ:AGRX)
www.kcregister.com - May 12 at 6:38 PM
News IconAgile Therapeutics Inc (AGRX) Rating Reiterated by FBR & Co. - Washington News Wire (NASDAQ:AGRX)
washingtonnewswire.com - May 11 at 4:50 AM
News IconPerformance Recap and Target Perspective on Agile Therapeutics, Inc. (NASDAQ:AGRX) - B.O.D.Y Confidential (NASDAQ:AGRX)
www.bodyconfidential.com - May 10 at 4:47 AM
sg.finance.yahoo.com logoAgile Therapeutics reports 1Q loss (NASDAQ:AGRX)
sg.finance.yahoo.com - May 9 at 6:18 PM
publicnow.com logoAgile Therapeutics Reports First Quarter 2016 Financial Results (NASDAQ:AGRX)
www.publicnow.com - May 9 at 4:28 PM
biz.yahoo.com logoQ1 2016 Agile Therapeutics Inc Earnings Release - After Market Close (NASDAQ:AGRX)
biz.yahoo.com - May 9 at 7:07 AM
News IconEarnings Outlook on Agile Therapeutics, Inc. (NASDAQ:AGRX) - B.O.D.Y Confidential (NASDAQ:AGRX)
www.bodyconfidential.com - May 4 at 11:41 PM
News IconAverage Analyst Rating for Agile Therapeutics, Inc. (NASDAQ:AGRX) - B.O.D.Y Confidential (NASDAQ:AGRX)
www.bodyconfidential.com - May 2 at 6:54 PM
publicnow.com logoAgile Therapeutics to Present at the 15th Annual Needham Healthcare Conference (NASDAQ:AGRX)
www.publicnow.com - March 30 at 4:21 PM
sg.finance.yahoo.com logoAgile Therapeutics reports 4Q loss (NASDAQ:AGRX)
sg.finance.yahoo.com - March 9 at 5:09 PM
finance.yahoo.com logoAgile Therapeutics Reports Fourth Quarter and Full Year 2015 Financial Results (NASDAQ:AGRX)
finance.yahoo.com - March 9 at 4:10 PM
finance.yahoo.com logoAgile Therapeutics to Present at the 28th Annual ROTH Conference (NASDAQ:AGRX)
finance.yahoo.com - March 3 at 4:15 PM
biz.yahoo.com logoAGILE THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Finan (NASDAQ:AGRX)
biz.yahoo.com - February 24 at 4:22 PM

Social

Agile Therapeutics (NASDAQ:AGRX) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff